Release Date: 13/09/10 16:17 Summary: Change in substantial holding from WAM Price Sensitive: No Download Document 91.12KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%